Understanding Glucose Data Visualization

Summary

This study examines how people understand different types of blood sugar charts. We want to learn which charts are easiest to read, which feel most understandable, and which people prefer. You will look at a few charts that show blood sugar patterns. Then you will answer questions about how clear and understandable each chart feels to you. By learning what works best for both patients and healthcare providers, this study will help improve how blood sugar information is shown in the future.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 120

Inclusion criteria:

You may be able to join this study if you have ALL the following criteria:
1. Are 18 years of age or older
2. Have Type 1 diabetes, Type 2 diabetes, pre-diabetes, or gestational diabetes
3. Can read and understand English
4. Have access to a computer or smartphone to complete an online survey

Exclusion criteria:

You are not eligible to join if you:
1. Are under 18 years old
2. Do not have diabetes, pre-diabetes, or gestational diabetes
3. Cannot read or understand English

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Prospective participants may reach out using the information below.

Principal investigator:

Fateme Rajabiyazdi

Clinical trial:

No

REB-ID:

REB25-2072